<?xml version="1.0" encoding="UTF-8" standalone="yes"?><response><header><requestMsgID></requestMsgID><responseTime>2025-11-17 18:38:07.387</responseTime><responseMsgID></responseMsgID><successYN>Y</successYN><resultCode>00</resultCode><resultMsg>NORMAL SERVICE.</resultMsg></header><body><item><biblioSummaryInfoArray><biblioSummaryInfo><applicationDate>2018.09.11</applicationDate><applicationFlag>특허</applicationFlag><applicationNumber>10-2024-7040905</applicationNumber><claimCount>1</claimCount><examinerName> </examinerName><finalDisposal> </finalDisposal><inventionTitle>인간 시토메갈로바이러스 면역원성 조성물</inventionTitle><inventionTitleEng>HUMAN CYTOMEGALOVIRUS IMMUNOGENIC COMPOSITION</inventionTitleEng><openDate>2025.01.10</openDate><openNumber>10-2025-0006307</openNumber><originalApplicationDate>2018.09.11</originalApplicationDate><originalApplicationKind>국제출원/분할</originalApplicationKind><originalApplicationNumber>10-2020-7010481</originalApplicationNumber><originalExaminationRequestDate>2025.01.09</originalExaminationRequestDate><originalExaminationRequestFlag>Y</originalExaminationRequestFlag><publicationDate> </publicationDate><publicationNumber> </publicationNumber><registerDate> </registerDate><registerNumber> </registerNumber><registerStatus>공개</registerStatus><translationSubmitDate>2024.12.10</translationSubmitDate></biblioSummaryInfo></biblioSummaryInfoArray><ipcInfoArray><ipcInfo><ipcDate>(2006.01.01)</ipcDate><ipcNumber>A61K 39/245</ipcNumber></ipcInfo><ipcInfo><ipcDate>(2006.01.01)</ipcDate><ipcNumber>A61K 39/39</ipcNumber></ipcInfo><ipcInfo><ipcDate>(2006.01.01)</ipcDate><ipcNumber>A61P 31/22</ipcNumber></ipcInfo><ipcInfo><ipcDate>(2006.01.01)</ipcDate><ipcNumber>A61K 39/00</ipcNumber></ipcInfo></ipcInfoArray><familyInfoArray><familyInfo><familyApplicationNumber>1020207010481</familyApplicationNumber></familyInfo></familyInfoArray><abstractInfoArray><abstractInfo><astrtCont> 본 발명은 HCMV gB 항원, HCMV gH/gL/UL128/UL130/UL131 오량체 복합체 항원 및 Th1-유도 아주반트를 포함하는 면역원성 조성물에 관한 것이다. 본 발명은 추가로 HCMV 백신으로서 사용하기 위한 면역원성 조성물에 관한 것이다. </astrtCont></abstractInfo></abstractInfoArray><internationalInfoArray><internationalInfo><internationOpenDate>2019.03.21</internationOpenDate><internationOpenNumber>WO2019052975</internationOpenNumber><internationalApplicationDate>2018.09.11</internationalApplicationDate><internationalApplicationNumber>PCT/EP2018/074369</internationalApplicationNumber></internationalInfo></internationalInfoArray><claimInfoArray><claimInfo><claim>1. HCMV gB 항원; HCMV gH/gL/UL128/UL130/UL131 오량체 복합체 항원; 및 Th1-유도 아주반트를 포함하는 면역원성 조성물의 용도.</claim></claimInfo></claimInfoArray><applicantInfoArray><applicantInfo><address>프랑스 리용 에스파세 앙리 발리** (우편번호:*****)</address><code>520000258583</code><country>프랑스</country><engName>Sanofi Pasteur</engName><name>사노피 파스퇴르</name></applicantInfo></applicantInfoArray><inventorInfoArray><inventorInfo><address>프랑스 에프-***** 불리 쉐...</address><code> </code><country>프랑스</country><engName>CHAUX, Pascal</engName><name>샤욱스, 파스칼</name></inventorInfo><inventorInfo><address>프랑스 에프-*****...</address><code> </code><country>프랑스</country><engName>DUMAS, Rafaela</engName><name>두마스, 라파엘라</name></inventorInfo><inventorInfo><address>프랑스 에프-***** 그...</address><code> </code><country>프랑스</country><engName>HAENSLER, Jean</engName><name>핸슬러, 쟝</name></inventorInfo><inventorInfo><address>프랑스 에프-***** ...</address><code> </code><country>프랑스</country><engName>PICHON, Sylvie</engName><name>피숑, 실비</name></inventorInfo><inventorInfo><address>프랑스 에프-***** 플뢰히...</address><code> </code><country>프랑스</country><engName>PIRAS-DOUCE, Fabienne</engName><name>피라스-두스, 파비엔</name></inventorInfo></inventorInfoArray><agentInfoArray><agentInfo><address>서울특별시 종로구 사직로*길 **, 세양빌딩 (내자동) *층(김.장법률사무소)</address><code>919980003619</code><country>대한민국</country><engName>YANG, Young June</engName><name>양영준</name></agentInfo><agentInfo><address>서울 중구 정동길 **-** (정동, 정동빌딩) **층(김.장법률사무소)</address><code>919980000478</code><country>대한민국</country><engName>KIM, Young</engName><name>김영</name></agentInfo></agentInfoArray><priorityInfoArray><priorityInfo><priorityApplicationCountry>유럽특허청(EPO)</priorityApplicationCountry><priorityApplicationDate>2017.09.13</priorityApplicationDate><priorityApplicationNumber>17306179.7</priorityApplicationNumber></priorityInfo></priorityInfoArray><designatedStateInfoArray/><priorArtDocumentsInfoArray/><legalStatusInfoArray><legalStatusInfo><commonCodeName>수리 (Accepted) </commonCodeName><documentEngName>[Divisional Application(International Application)] Patent Application</documentEngName><documentName>[분할출원(국제출원)]특허출원서</documentName><receiptDate>2024.12.10</receiptDate><receiptNumber>1-1-2024-1366841-10</receiptNumber></legalStatusInfo><legalStatusInfo><commonCodeName>수리 (Accepted) </commonCodeName><documentEngName> </documentEngName><documentName>[심사청구]심사청구서·우선심사신청서</documentName><receiptDate>2025.01.09</receiptDate><receiptNumber>1-1-2025-0032199-16</receiptNumber></legalStatusInfo></legalStatusInfoArray><imagePathInfo><docName>1020247040905.jpg</docName><largePath>http://plus.kipris.or.kr/kiprisplusws/fileToss.jsp?arg=6c650beb4cee9ce4122b704b88878c93aef205ad81442f7bbcadc4dcbaad03db3fecf907700015775ecd08ebfdabf969531ecbdac2017696336f5c4d85379129cd7ef29392aa2829</largePath><path>http://plus.kipris.or.kr/kiprisplusws/fileToss.jsp?arg=ed43a0609e94d6e22d01c5c32ba711cf2cfb5fe4032a17455d8e4d479ac21174ca9fd4927ec3c263af6c5ccbf25b5c4517aa6f2d9d20a9ccdf9dc0983ad5fa7c34251ca8643c6ad8</path></imagePathInfo><rndInfoArray/></item></body><count><numOfRows>1</numOfRows><pageNo>1</pageNo><totalCount>1</totalCount></count></response>